Heart failure therapy in patients with coronary artery disease

Current Opinion in Pharmacology

Volumn 13, Issue 2, 2013, Pages 205-209

  Taylor, Clare J ^a   Hobbs, F D Richard ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; ISOSORBIDE MONONITRATE; IVABRADINE; LOOP DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; NATRIURETIC FACTOR; NITRATE; ROSIGLITAZONE; SPIRONOLACTONE;

ANGINA PECTORIS; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART INFARCTION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SECONDARY PREVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN DEATH; SURVIVAL RATE;

CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS;

EID: 84879409624     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.01.009     Document Type: Review

References (37)

1. European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 Eur Heart J 33 2012 1787 1847
2. A. Torabi, J.G.F. Cleland, N.K. Khan, P.H. Loh, A.L. Clark, F. Alamgir, J.L. Caplin, A.S. Rigby, and K. Goode The timing of development and subsequent clinical course of heart failure after myocardial infarction Eur Heart J 29 2008 859 870 (Pubitemid 351499497)
3. J.E. Ho, P. Gona, M.J. Pencina, J.V. Tu, P.C. Austin, R.S. Vasan, W.B. Kannel, R.B. D'Agostino, D.S. Lee, and D. Levy Discriminatary clinical features of heart failure with preserved ejection fraction vs. reduced ejection fraction in the community Eur Heart J 33 2012 1734 1741
4. J.A. Ezekowitz, P. Kaul, J.E. Bakal, P.W. Armstrong, R.C. Welsh, and F.A. McAlister Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction J Am Coll Cardiol 53 2009 13 20
5. D. Westermann, M. Kasner, P. Steendijk, F. Spillmann, A. Riad, K. Weitmann, W. Hoffmann, W. Poller, M. Pauschinger, H.-P. Schultheiss, and C. Tschope Role of left ventricular stiffness in heart failure with normal ejection fraction Circulation 117 2008 2051 2060 (Pubitemid 351572179)
6. M. Gheorghiade, and R.O. Bonow Chronic heart failure in the United States. A manifestation of coronary artery disease Circulation 97 1998 282 289 (Pubitemid 28067315)
7. S.P. deBoer, E.H. Barnes, C.M. Westerhaut, R.J. Simes, C.B. Granger, A. Kastrati, P. Widimsky, M.J. de Boer, F. Zijlstra, and E. Boersma High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration Am Heart J 161 2011 500 507
8. G.S. Bleumink, A.M. Knetsch, M.C.J.M. Sturkenboom, S.M.J.M. Strauss, A. Hofman, J.W. Deckers, J.C.M. Witteman, and B.H.Ch. Stricker Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure Eur Heart J 25 2004 1614 1619 (Pubitemid 39209281)
9. M. Davies, F. Hobbs, R. Davis, J. Kenkre, A.K. Roalfe, R. Hare, D. Wosornu, and R.J. Lancashire Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study Lancet 358 2001 439 444 (Pubitemid 32769849)
10. S. Stewart, K. MacIntyre, D.J. Hole, S. Capewell, and J.J. McMurray More 'malignant' than cancer? Five-year survival following a first admission for heart failure Eur J Heart Fail 3 2001 315 322 (Pubitemid 32895839)
11. T.H.L. Jemtel, M. Padaletti, and S. Jelic Diagnostic and therapeutic challenges in patients with co-existent chronic obstructive pulmonary disease and chronic heart failure J Am Coll Cardiol 49 2007 171 180 (Pubitemid 46054390)
12. F.H. Rutten, M.J. Cramer, D.E. Grobbee, A.P. Sachs, J.H. Kirkels, J.W. Lammes, and A.W. Hoes Unrecognised heart failure in elderly patients with stable chronic obstructive pulmonary disease Eur Heart J 26 2005 1887 1894 (Pubitemid 41253302)
13. Escobar c, J.L. Santiago-Ruiz, and L. Manzano Diagnosis of heart failure in elderly patients: a clinical challenge Eur J Heart Fail 13 2011 1152
14. J. Mant, J. Doust, A. Roalfe, P. Barton, M.R. Cowie, and P. Glasziou Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care Health Technol Assess 13 2009
15. National Institute for Clinical Excellence Chronic Heart Failure - Management of Chronic Heart Failure in Adults in Primary and Secondary Care 2010 NICE
16. F.D. Hobbs, R.C. Davis, A.K. Roalfe, R. Hare, and M.K. Davies Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations Heart 90 2004 866 870 (Pubitemid 39005929)
17. C.J. Taylor, A.K. Roalfe, R. Iles, and F.D.R. Hobbs Ten-year prognosis of heart failure in the community: follow up data from the Echocardiographic Heart of England Screening Study (ECHOES) Eur J Heart Fail 14 2012 176 184
18. National Institute for Health and Clinical Excellence Myocardial Infarction: Secondary Prevention 2007 NICE
19. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 325 1991 293 302
20. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr., and T.E. Cuddy Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677 (see comment)
21. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
22. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Raniker, R. Bittman, S. Hurley, J. Kleiman, and M. Gatlin Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators N Engl J Med 348 2003 1309 1321
23. B. Pitt The role of aldosterone blockade in patients with heart failure Heart Fail Rev 10 2005 79 83 (Pubitemid 40895319)
24. National Institute for Health and Clinical Excellence Clinical Management of Primary Hypertension in Adults 2011 NICE
25. J.N. Cohn, G. Johnson, S. Ziesche, F. Cobb, G. Francis, F. Tristani, R. Smith, W.B. Dunkman, H. Loeb, and M. Wong A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
26. K. Swedberg, M. Komajda, M. Bohm, J.S. Borer, I. Ford, A. Dubost-Brama, G. Lerebours, and L. Tavazzi Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
27. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, and J. Knuuti Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
28. J. Kjekshus, E. Apetrei, V. Barrios, M. Böhm, J.G. Cleland, J.H. Cornel, P. Dunselman, C. Fonseca, A. Goudev, and P. Grande Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261 (Pubitemid 350190755)
29. R.P. Ryan, R.J. McManus, J. Mant, J.A. Macleod, and F.D. Hobbs Statins in HF: retrospective cohort study using routine primary care data Ann Med 41 2009 490 496
30. C. Taylor, and F.D.R. Hobbs Type 2 diabetes, thiazolidinediones and cardiovascular risk Br J Gen Pract 59 2009 520 524
31. J.G. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, and J. Taylor The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345 (Pubitemid 44453578)
32. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, B. Olofsson, and J. Ostergren Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781 (Pubitemid 37093918)
33. W.J. Paulus, and J.J.M. van Ballegoij Treatment of heart failure with normal ejection fraction. An inconvenient truth! J Am Coll Cardiol 55 2010 526 537
34. K. Dickstein, P.E. Vardas, A. Auricchio, J.C. Daubert, C. Linde, J. McMurray, P. Ponikowski, S.G. Priori, R. Sutton, and D.J. van Veldhuisen 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur J Heart Fail 12 2010 1143 1153
35. A.S. Tang, G.A. Wells, M. Talajic, M.O. Arnold, R. Sheldon, S. Connolly, S.H. Hohnloser, G. Nichol, D.H. Birnie, and J.L. Sapp Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
36. A.J. Moss, W.J. Hall, D.S. Cannom, H. Klein, M.W. Brown, J.P. Daubert, N.A. Estes III, E. Foster, H. Greenberg, S.L. Higgins, and M.A. Pfeffer Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
37. L.M. Ptaszek, M. Mansour, J.N. Ruskin, and K.R. Chien Towards regenerative therapy for cardiac disease Lancet 379 2012 933 942